Qinheli Biomedical is a tumor micro-environment-responsive drug developer
Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 1, 2021 | Private Equity(PE) | — | 1 | — | — | Detail |
Jul 16, 2019 | Seed | ¥60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Yunsheng Touzi | — | Private Equity(PE) |
Tengyuan Fund | — | Seed |